VANCOUVER, September 22nd, 2025 – TheNewswire - Aequus Pharmaceuticals Inc. (TSX-V: AQS) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licensing and partnerships, is pleased to announce Giovanni Di Genova has agreed to join the Aequus Board of Directors, subject to the completion of his PIF and TSX approval, effective Friday September 12th, 2025.“Aequus is pleased to welcome Giovanni Di Genova as a new director and we are eag ...